Advance developments in life sciences with a strategic financing partner
Financing a better future
Financial solutions to grow life sciences
From food testing and blood analysis to DNA sequencing and testing fetal irregularities, life sciences are everywhere in our daily lives. Laboratories, universities, research centers, growth-stage companies and healthcare providers are among those engaged in the development and adoption of life sciences to enable a better future.
Advancing diagnosis and discovery is made easier with the world’s latest technologies. However, these technologies and equipment must be made accessible to drive adoption—and that is where an experienced financial solutions partner can enable the path forward.
Many of the world's leading life sciences companies trust DLL's experienced and knowledgeable team to provide the right financial solutions for their customers.
Benefits of financing life sciences technology
Technology refresh
Provide an upgrade path to future technology, making migration to the latest platform easy and more affordable in the future.
Bundled solutions
Combine technology with consumables, software, services and insurance in one monthly payment to preserve capital and reduce upfront expenses.
Customize financing options
Tailor financial solutions by project and customer objective, including budget cycle, financial priorities, and tax or accounting considerations.*
Disclaimer: The above does not constitute a financing offer. *Always consult your tax advisor. DLL does not provide tax or accounting advice.
How innovative financing equips
state-of-the-art laboratories and attracts top talent
Meet the team
Paul Tweehuysen
Paul is a Senior Account Manager at DLL and leads the UK Life Sciences team. He provides strategic guidance to our team of expert Account Managers who are on ...
Janet Judd
Janet is an Account Manager at DLL and is responsible for maintaining DLL’s relationships with organisations that manufacture and distribute equipment to laboratories.
Nick Hoof
You may already know Nick; he has strong relationships with many laboratory equipment suppliers and is a regular at industry events. Nick has over 10 years of experience ...
Rachel Drage
Rachel is the newest member of the UK Healthcare team, joining DLL in November 2023. Having graduated from university in the field of Biomedical Science ...
Dharmesh Chouhan
With over 20 years’ financing experience, Dharmesh has most recently been helping the public sector acquire equipment that directly improves patient care and wellbeing. ...
“…DLL offered the most straightforward and flexible arrangements for a growth company like Nuclera”
-Jiahao Huang, Chief Financial Officer, Nuclera
Explore more resources
Sharing in vibrant life science ecosystems
Sharing is at the heart of a vibrant life science ecosystem – sharing of knowledge, sharing of experience and, it would seem, sharing equipment that would otherwise be inaccessible. However, shared scientific equipment is only viable if three parts of the equation are balanced. First, you need to offer state-of the art equipment. Second, you need sufficient demand for the equipment, which means it only really works on larger campuses. Finally, the access, maintenance, and servicing require proactive monitoring and management on a day-to-day basis. Because of this, operating a shared scientific service has the potential to be expensive. However, there is new payment model that has the potential to reduce costs for the ecosystem operator – “Pay-per-use” (PPU).
How innovative financing equips state-of-the-art laboratories and attracts top talent
In the second of our regular series discussing challenges facing the UK life sciences industry, Dr Stephen Franklin reflects on his time as a PhD student, how he grappled with (and often lost against), obsolete and overworked equipment.
Supporting growth in life sciences. Laboratory equipment financing enables optimal use of resources
Nuclera, a UK-based biotechnology company, was founded in 2013 by three PhD students studying at the University of Cambridge. Whilst working on their dissertations, they found that the long lead time and high costs associated with protein prototyping created a significant barrier for scientists when it came to their research.
Advancing life sciences with financial solutions
DLL supports research, development and diagnosis with comprehensive finance offerings and industry expertise.